Shuai Wu
The Wistar Institute(US)North University of China(CN)National Sun Yat-sen University(TW)Chongqing University(CN)University of Massachusetts Chan Medical School(US)Guangxi University of Science and Technology(CN)Anhui Medical University(CN)Quantum Devices (United States)(US)Xi'an University of Technology(CN)Advanced Materials and Devices (United States)(US)
Publications by Year
Research Areas
Chromatin Remodeling and Cancer, Peptidase Inhibition and Analysis, Cancer Mechanisms and Therapy, Signaling Pathways in Disease, Histone Deacetylase Inhibitors Research
Most-Cited Works
- → NAD+ metabolism governs the proinflammatory senescence-associated secretome(2019)380 cited
- → ARID1A-mutated ovarian cancers depend on HDAC6 activity(2017)224 cited
- → N6-Methylation of Adenosine of FZD10 mRNA Contributes to PARP Inhibitor Resistance(2019)190 cited
- → HDAC6 Inhibition Synergizes with Anti-PD-L1 Therapy in ARID1A-Inactivated Ovarian Cancer(2019)120 cited
- → Targeting glutamine dependence through GLS1 inhibition suppresses ARID1A-inactivated clear cell ovarian carcinoma(2021)119 cited
- → The Tumor Suppressor ARID1A Controls Global Transcription via Pausing of RNA Polymerase II(2018)102 cited